TREATMENT FOR DEPRESSION & CHRONIC PAIN | OUR BLOG

WELCOME TO OUR KETAMINE TREATMENT CENTER’S BLOG

Our blog covers a variety of topics, ranging from news about ketamine research, new depression treatments, chronic pain management, and more. Be sure to subscribe to receive our monthly e-Newsletter so you never miss a blog post!

FEATURED MEDIA

Suicidal Depressed Man Says Ketamine Saved His Life

First-Hand Testimonial from a Ketamine Patient

How the Approval of Esketamine has Helped Shift the Perception of Ketamine and Other Psychedelics

How the Approval of Esketamine has Helped Shift the Perception of Ketamine and Other Psychedelics

The history of ketamine goes back to 1962, when it was first synthesized by American scientist, Calvin Stevens, at the Parke Davis Laboratories. The drug was known as a fast acting anesthetic and, eventually, a recreational hallucinogen. However, in the late 1990s, its antidepressive benefits were discovered. Research performed over the last two decades suggests that ketamine infusions could rapidly and effectively ease symptoms of depression and anxiety in up to 70% of patients, a discovery which marked the beginning of ketamine clinics popping up all over the country.

The Correlation Between Migraine Headaches, Depression & Anxiety

The Correlation Between Migraine Headaches, Depression & Anxiety

Migraines are extremely widespread in the United States, and much more debilitating than people realize. There are about 39 million people who struggle daily with this neurological disease, which makes it the 3rd most prevalent illness in the world. Not only do these severe and persistent headaches affect daily life, but they may be connected with mental health disorders such as depression and anxiety. Current research is being performed to figure out what the link may be. For example, do migraines lead to depression and anxiety? Or is it psychiatric illness that leads to migraines?

Rolling Out the Red Carpet for Depression Treatment: How Celebrities Help Change the Stigma of Depression

Rolling Out the Red Carpet for Depression Treatment: How Celebrities Help Change the Stigma of Depression

One of the leading causes of disability in the U.S. is major depressive disorder (MDD), affecting more than 16.1 million adults each year. Another perhaps more shocking statistic is that about 80% of those people never seek treatment, for various reasons. However, one of the main reasons why so many individuals fail to seek treatment is because of the stigma associated with having a mental health condition. A stigma that, unfortunately, is alive and thriving in our society today.

Ketamine Saves Lives, In More Ways than One

Ketamine Saves Lives, In More Ways than One

Last year, on June 23, twelve young boys—members of the Wild Boars youth soccer team—and their coach were unexpectedly trapped inside an underground cave system in Thailand. When flood water quickly and unexpectedly rose, their exploration went from fun and exciting to frightening and dangerous…and fast. The water blocked off their exit and trapped them inside, with their only option to go deeper into the cave. They were trapped in the cave for over two weeks before cave rescue teams from China, Myanmar, Laos, Australia, the UK, and the United States finally reached them on July 10.

Spravato is FDA-Approved…and Here’s What You Need to Know

Spravato is FDA-Approved…and Here’s What You Need to Know

The recent FDA approval of the use of esketamine for treatment-resistant depression means many Americans suffering will soon find relief. The drug, Spravato, was approved for patients who have failed to respond at all to at least two other antidepressant medications. After years of clinical trials, the decision to officially approve Spravato took a month before a panel of experts voted in favor of the new treatment. Since treatment-resistant depression plagues so many among us, this new treatment has generated tremendous hope for depression sufferers, their loved ones, and their mental health clinicians.

Depression and Suicide in Young Adults: The Role of Social Media

Depression and Suicide in Young Adults: The Role of Social Media

Depression is a mental disorder that affects 350 million people world wide. According to a medical paper published by Louisiana State University Health Sciences Center, people in the United States 18 years and older make up 4.6% of those 350 million. The study, which surveyed 600,000—or 0.1836%—of the US population, concluded that those who spend more than 6 hours in front of a screen were at a greater risk for depression.

The Impending FDA Approval of Esketamine and What It Means for Depression Treatment

The Impending FDA Approval of Esketamine and What It Means for Depression Treatment

Since it was developed in 2016, we’ve blogged several times about esketamine—the isomer of ketamine being developed by Janssen Pharmaceuticals, designed to rapidly alleviate the symptoms of treatment-resistant depression. Esketamine, which will be administered intranasally, was granted breakthrough medication status by the FDA and fast-tracked for approval. And the time for approval is here.

The Discovery of Hope: How Ketamine for Depression Came to Be

The Discovery of Hope: How Ketamine for Depression Came to Be

Over the past several years, ketamine has received a growing amount of media attention. As a treatment for depression, no other medication has shown this much promise since Prozac was discovered in the 1980s. Ketamine has been hailed as “miraculous,” and a “wonder drug,” alleviating depressive symptoms in up to 70% of patients…even those who failed to respond to depression treatment after depression treatment. What’s even more spectacular is the speed in which ketamine works—patients know whether ketamine will work for them after only 1-2 infusions.

Predicting Postpartum Depression: 4 Factors to Determine Risk & the Severity of Symptoms

Predicting Postpartum Depression: 4 Factors to Determine Risk & the Severity of Symptoms

For many women, giving birth is the most joyous event of their lives. But, every year, for more than 3 million women in the U.S., child birth results in the development of postpartum depression—and it can be devastating for mother and child alike. Most cases of postpartum depression are resolved within a matter of months, with such treatments as talk therapy, antidepressants, and ketamine infusions. However, some cases of postpartum depression can worsen in time, ultimately increasing the mother’s risk for developing chronic, severe depression.

CONTACT OUR TEAM

Learn more about ketamine treatment for eating disorders and other mental health conditions, and find out if you or a loved one is a candidate.

 

Contact Us »

ketamine administration by anesthesiologist eve langston

CONTACT VITALITAS DENVER

Complete the brief form below and a member of our team will contact you to answer your questions, address any concerns you may have, and point you in the direction of health & wellbeing.

CALL OR EMAIL US

phone: (720) 724-8075
fax: (720) 306-5383

VISIT OUR KETAMINE CLINICS

LITTLETON, CO KETAMINE CLINIC

26 West Dry Creek Circle; Suite 200
Littleton, CO 80120

HOURS:

Monday: 8:30 am - 4:00pm
Thursday: 12:00 pm - 8:00 pm
Friday: 9:00am - 3:00 pm
Saturday: 9:00am - 3:00 pm

WESTMINSTER, CO KETAMINE CLINIC

12110 North Pecos St; Suite 160
Westminster, CO 80234

HOURS:

Tuesday: 12:00 pm  - 8:00 pm
Wednesday: 12:00 pm  - 8:00 pm
Friday: 12:00 pm  - 8:00 pm

GET SOCIAL WITH US

Proud Members of

       

Proud Supporters of

HIPAA